CD44 and neoplasm: In addition, the ratio of CD31 and CD45 was limitedly affected by EVs, while EVs derived from tumor cells significantly increased the ratio of CD105 and CD44+ CD90+ CD133+ in BMSCs (Figures 3(b)–3(e)).